List of Tables
Table 1. Global Colorectal Cancer Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Colorectal Cancer Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Colorectal Cancer Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Colorectal Cancer Drugs Sales (Units) of Key Manufacturers (2018-2023)
Table 5. Global Colorectal Cancer Drugs Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Colorectal Cancer Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Colorectal Cancer Drugs Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Colorectal Cancer Drugs Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Colorectal Cancer Drugs, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Colorectal Cancer Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Colorectal Cancer Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Colorectal Cancer Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Colorectal Cancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Colorectal Cancer Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Colorectal Cancer Drugs Sales by Region (2018-2023) & (Units)
Table 18. Global Colorectal Cancer Drugs Sales Market Share by Region (2018-2023)
Table 19. Global Colorectal Cancer Drugs Sales by Region (2024-2029) & (Units)
Table 20. Global Colorectal Cancer Drugs Sales Market Share by Region (2024-2029)
Table 21. Global Colorectal Cancer Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Colorectal Cancer Drugs Revenue Market Share by Region (2018-2023)
Table 23. Global Colorectal Cancer Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Colorectal Cancer Drugs Revenue Market Share by Region (2024-2029)
Table 25. North America Colorectal Cancer Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Colorectal Cancer Drugs Sales by Country (2018-2023) & (Units)
Table 27. North America Colorectal Cancer Drugs Sales by Country (2024-2029) & (Units)
Table 28. North America Colorectal Cancer Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Colorectal Cancer Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Colorectal Cancer Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Colorectal Cancer Drugs Sales by Country (2018-2023) & (Units)
Table 32. Europe Colorectal Cancer Drugs Sales by Country (2024-2029) & (Units)
Table 33. Europe Colorectal Cancer Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Colorectal Cancer Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Colorectal Cancer Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Colorectal Cancer Drugs Sales by Region (2018-2023) & (Units)
Table 37. Asia Pacific Colorectal Cancer Drugs Sales by Region (2024-2029) & (Units)
Table 38. Asia Pacific Colorectal Cancer Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Colorectal Cancer Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Colorectal Cancer Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Colorectal Cancer Drugs Sales by Country (2018-2023) & (Units)
Table 42. Latin America Colorectal Cancer Drugs Sales by Country (2024-2029) & (Units)
Table 43. Latin America Colorectal Cancer Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Colorectal Cancer Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Colorectal Cancer Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Colorectal Cancer Drugs Sales by Country (2018-2023) & (Units)
Table 47. Middle East & Africa Colorectal Cancer Drugs Sales by Country (2024-2029) & (Units)
Table 48. Middle East & Africa Colorectal Cancer Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Colorectal Cancer Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Colorectal Cancer Drugs Sales (Units) by Type (2018-2023)
Table 51. Global Colorectal Cancer Drugs Sales (Units) by Type (2024-2029)
Table 52. Global Colorectal Cancer Drugs Sales Market Share by Type (2018-2023)
Table 53. Global Colorectal Cancer Drugs Sales Market Share by Type (2024-2029)
Table 54. Global Colorectal Cancer Drugs Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Colorectal Cancer Drugs Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Colorectal Cancer Drugs Revenue Market Share by Type (2018-2023)
Table 57. Global Colorectal Cancer Drugs Revenue Market Share by Type (2024-2029)
Table 58. Global Colorectal Cancer Drugs Price (USD/Unit) by Type (2018-2023)
Table 59. Global Colorectal Cancer Drugs Price (USD/Unit) by Type (2024-2029)
Table 60. Global Colorectal Cancer Drugs Sales (Units) by Application (2018-2023)
Table 61. Global Colorectal Cancer Drugs Sales (Units) by Application (2024-2029)
Table 62. Global Colorectal Cancer Drugs Sales Market Share by Application (2018-2023)
Table 63. Global Colorectal Cancer Drugs Sales Market Share by Application (2024-2029)
Table 64. Global Colorectal Cancer Drugs Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Colorectal Cancer Drugs Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Colorectal Cancer Drugs Revenue Market Share by Application (2018-2023)
Table 67. Global Colorectal Cancer Drugs Revenue Market Share by Application (2024-2029)
Table 68. Global Colorectal Cancer Drugs Price (USD/Unit) by Application (2018-2023)
Table 69. Global Colorectal Cancer Drugs Price (USD/Unit) by Application (2024-2029)
Table 70. AB Science Corporation Information
Table 71. AB Science Description and Business Overview
Table 72. AB Science Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. AB Science Colorectal Cancer Drugs Product
Table 74. AB Science Recent Developments/Updates
Table 75. Amgen Corporation Information
Table 76. Amgen Description and Business Overview
Table 77. Amgen Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Amgen Colorectal Cancer Drugs Product
Table 79. Amgen Recent Developments/Updates
Table 80. Array BioPharma Corporation Information
Table 81. Array BioPharma Description and Business Overview
Table 82. Array BioPharma Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Array BioPharma Colorectal Cancer Drugs Product
Table 84. Array BioPharma Recent Developments/Updates
Table 85. Bayer Corporation Information
Table 86. Bayer Description and Business Overview
Table 87. Bayer Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Bayer Colorectal Cancer Drugs Product
Table 89. Bayer Recent Developments/Updates
Table 90. Boehringer Ingelheim Corporation Information
Table 91. Boehringer Ingelheim Description and Business Overview
Table 92. Boehringer Ingelheim Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Boehringer Ingelheim Colorectal Cancer Drugs Product
Table 94. Boehringer Ingelheim Recent Developments/Updates
Table 95. Bristol-Myers Squibb Corporation Information
Table 96. Bristol-Myers Squibb Description and Business Overview
Table 97. Bristol-Myers Squibb Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Bristol-Myers Squibb Colorectal Cancer Drugs Product
Table 99. Bristol-Myers Squibb Recent Developments/Updates
Table 100. Elli Lilly Corporation Information
Table 101. Elli Lilly Description and Business Overview
Table 102. Elli Lilly Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Elli Lilly Colorectal Cancer Drugs Product
Table 104. Elli Lilly Recent Developments/Updates
Table 105. Roch Corporation Information
Table 106. Roch Description and Business Overview
Table 107. Roch Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Roch Colorectal Cancer Drugs Product
Table 109. Roch Recent Developments/Updates
Table 110. Hutchison MediPharma Corporation Information
Table 111. Hutchison MediPharma Description and Business Overview
Table 112. Hutchison MediPharma Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Hutchison MediPharma Colorectal Cancer Drugs Product
Table 114. Hutchison MediPharma Recent Developments/Updates
Table 115. Merck & Co., Inc. Corporation Information
Table 116. Merck & Co., Inc. Description and Business Overview
Table 117. Merck & Co., Inc. Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Merck & Co., Inc. Colorectal Cancer Drugs Product
Table 119. Merck & Co., Inc. Recent Developments/Updates
Table 120. Mologen Corporation Information
Table 121. Mologen Description and Business Overview
Table 122. Mologen Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Mologen Colorectal Cancer Drugs Product
Table 124. Mologen Recent Developments/Updates
Table 125. Regeneron Corporation Information
Table 126. Regeneron Description and Business Overview
Table 127. Regeneron Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. Regeneron Colorectal Cancer Drugs Product
Table 129. Regeneron Recent Developments/Updates
Table 130. Sanofi Corporation Information
Table 131. Sanofi Description and Business Overview
Table 132. Sanofi Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Sanofi Colorectal Cancer Drugs Product
Table 134. Sanofi Recent Developments/Updates
Table 135. Sumitomo Dainippon Corporation Information
Table 136. Sumitomo Dainippon Description and Business Overview
Table 137. Sumitomo Dainippon Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Sumitomo Dainippon Colorectal Cancer Drugs Product
Table 139. Sumitomo Dainippon Recent Developments/Updates
Table 140. Taiho Pharmaceutical Corporation Information
Table 141. Taiho Pharmaceutical Description and Business Overview
Table 142. Taiho Pharmaceutical Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Taiho Pharmaceutical Colorectal Cancer Drugs Product
Table 144. Taiho Pharmaceutical Recent Developments/Updates
Table 145. Vaccinogen Corporation Information
Table 146. Vaccinogen Description and Business Overview
Table 147. Vaccinogen Colorectal Cancer Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 148. Vaccinogen Colorectal Cancer Drugs Product
Table 149. Vaccinogen Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Colorectal Cancer Drugs Distributors List
Table 153. Colorectal Cancer Drugs Customers List
Table 154. Colorectal Cancer Drugs Market Trends
Table 155. Colorectal Cancer Drugs Market Drivers
Table 156. Colorectal Cancer Drugs Market Challenges
Table 157. Colorectal Cancer Drugs Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Colorectal Cancer Drugs
Figure 2. Global Colorectal Cancer Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Colorectal Cancer Drugs Market Share by Type in 2022 & 2029
Figure 4. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Picture
Figure 5. Epidermal Growth Factor Receptor (EGFR) Inhibitors Product Picture
Figure 6. Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors Product Picture
Figure 7. BRAF or MEK Inhibitors Product Picture
Figure 8. Tyrosine Kinase (TKI) Inhibitors Product Picture
Figure 9. Immunomodulators Product Picture
Figure 10. Global Colorectal Cancer Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 11. Global Colorectal Cancer Drugs Market Share by Application in 2022 & 2029
Figure 12. Radiotherapy
Figure 13. Chemotherapy
Figure 14. Global Colorectal Cancer Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Colorectal Cancer Drugs Market Size (2018-2029) & (US$ Million)
Figure 16. Global Colorectal Cancer Drugs Sales (2018-2029) & (Units)
Figure 17. Global Colorectal Cancer Drugs Average Price (USD/Unit) & (2018-2029)
Figure 18. Colorectal Cancer Drugs Report Years Considered
Figure 19. Colorectal Cancer Drugs Sales Share by Manufacturers in 2022
Figure 20. Global Colorectal Cancer Drugs Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Colorectal Cancer Drugs Players: Market Share by Revenue in 2022
Figure 22. Colorectal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Colorectal Cancer Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 24. North America Colorectal Cancer Drugs Sales Market Share by Country (2018-2029)
Figure 25. North America Colorectal Cancer Drugs Revenue Market Share by Country (2018-2029)
Figure 26. United States Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Mexico Colorectal Cancer Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 29. Europe Colorectal Cancer Drugs Sales Market Share by Country (2018-2029)
Figure 30. Europe Colorectal Cancer Drugs Revenue Market Share by Country (2018-2029)
Figure 31. Germany Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. France Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. U.K. Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Italy Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Russia Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Asia Pacific Colorectal Cancer Drugs Sales Market Share by Region (2018-2029)
Figure 37. Asia Pacific Colorectal Cancer Drugs Revenue Market Share by Region (2018-2029)
Figure 38. China Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Taiwan Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Indonesia Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Thailand Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Malaysia Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Philippines Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Latin America Colorectal Cancer Drugs Sales Market Share by Country (2018-2029)
Figure 49. Latin America Colorectal Cancer Drugs Revenue Market Share by Country (2018-2029)
Figure 50. Mexico Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Brazil Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Argentina Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Middle East & Africa Colorectal Cancer Drugs Sales Market Share by Country (2018-2029)
Figure 54. Middle East & Africa Colorectal Cancer Drugs Revenue Market Share by Country (2018-2029)
Figure 55. Turkey Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. U.A.E Colorectal Cancer Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Global Sales Market Share of Colorectal Cancer Drugs by Type (2018-2029)
Figure 59. Global Revenue Market Share of Colorectal Cancer Drugs by Type (2018-2029)
Figure 60. Global Colorectal Cancer Drugs Price (USD/Unit) by Type (2018-2029)
Figure 61. Global Sales Market Share of Colorectal Cancer Drugs by Application (2018-2029)
Figure 62. Global Revenue Market Share of Colorectal Cancer Drugs by Application (2018-2029)
Figure 63. Global Colorectal Cancer Drugs Price (USD/Unit) by Application (2018-2029)
Figure 64. Colorectal Cancer Drugs Value Chain
Figure 65. Colorectal Cancer Drugs Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed